|
C16ORF57 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.45599999834545E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.33550000003257E-06 |
| Normal-vs-Stage2 |
4.582700E-03 |
| Normal-vs-Stage3 |
3.232400E-04 |
| Normal-vs-Stage4 |
2.169600E-01 |
| Stage1-vs-Stage2 |
3.861200E-01 |
| Stage1-vs-Stage3 |
4.729500E-02 |
| Stage1-vs-Stage4 |
1.939960E-01 |
| Stage2-vs-Stage3 |
2.655600E-01 |
| Stage2-vs-Stage4 |
1.835840E-01 |
| Stage3-vs-Stage4 |
1.927960E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.83329999964488E-08 |
| Normal-vs-AfricanAmerican |
1.968300E-04 |
| Normal-vs-Asian |
3.762300E-02 |
| Caucasian-vs-AfricanAmerican |
2.799400E-01 |
| Caucasian-vs-Asian |
2.609600E-01 |
| AfricanAmerican-vs-Asian |
8.553700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.31760000021686E-07 |
| Normal-vs-Female |
1.19530000008972E-07 |
| Male-vs-Female |
1.096550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.501800E-02 |
| Normal-vs-Extreme_Weight |
3.59439999997324E-06 |
| Normal-vs-Obese |
2.41280000001787E-06 |
| Normal-vs-Extreme_Obese |
8.299600E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.436300E-02 |
| Normal_Weight-vs-Obese |
9.399000E-03 |
| Normal_Weight-vs-Extreme_Obese |
2.998200E-01 |
| Extreme_Weight-vs-Obese |
2.101200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.346000E-01 |
| Obese-vs-Extreme_Obese |
6.122600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.649400E-04 |
| Normal-vs-Age(41-60Yrs) |
8.64620000040617E-08 |
| Normal-vs-Age(61-80Yrs) |
2.1174999997875E-07 |
| Normal-vs-Age(81-100Yrs) |
5.135400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.888200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.564200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.652300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.280800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.027600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.638200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.38730000212684E-08 |
| Normal-VS-Type2 PRCC |
7.984400E-03 |
| Normal-VS-KIRP CIMP |
8.630800E-04 |
| Normal-VS-Unclassified PRCC |
1.58104999999908E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.099680E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.791300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.347500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.15440000000045E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
2.437400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.786970E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.581700E-03 |
| Normal-vs-N1 |
1.920020E-03 |
| Normal-vs-N2 |
7.420400E-01 |
| N0-vs-N1 |
8.600400E-02 |
| N0-vs-N2 |
3.858000E-01 |
| N1-vs-N2 |
7.698800E-03 |
|
|
